AYTU BIOPHARMA INC (AYTU) Stock Cash Flow
USA - NASDAQ:AYTU - US0547548588 - Common Stock
2.02 USD
0 (0%)
| TTM (2025-9-30) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.07M | -13.56M | -15.84M | -17.05M | -110.17M | |||
| Depreciation Amortization | 4.75M | 5.38M | 8.27M | 8.82M | 10.25M | |||
| Income Taxes - Deferred | undefined | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | -4.90M | -5.73M | -4.66M | -5.80M | -10.86M | |||
| Interest Paid | 2.92M | 2.82M | 4.04M | 3.81M | 3.15M | |||
| Taxes Paid | 1.11M | 1.42M | 1.61M | null | null | |||
| Other non cash items | 11.86M | 11.98M | 10.84M | 8.91M | 81.96M | |||
| OPERATING CASH FLOW | -1.36M | -1.94M | -1.39M | -5.13M | -28.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.09M | -3.23M | null | null | null | |||
| Other Investing Activity | 151.00K | 668.00K | -329.00K | -120.00K | -3.25M | |||
| INVESTING CASH FLOW | -2.94M | -2.56M | -329.00K | -120.00K | -3.25M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 10.60M | 6.67M | -1.89M | -2.35M | -5.22M | |||
| Stock Issued/Repurchased | undefined | 14.84M | 3.47M | 15.58M | 11.69M | |||
| Dividend Paid | undefined | null | null | null | null | |||
| Other Financing Activity | -8.62M | -6.07M | -2.84M | -4.36M | -4.94M | |||
| FINANCING CASH FLOW | 16.83M | 15.44M | -1.26M | 8.87M | 1.53M | |||
| Exchange Rate Effect | undefined | null | null | null | null | |||
| CHANGE IN CASH | 12.52M | 10.95M | -2.98M | 3.62M | -30.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -1.36M | -1.94M | -1.39M | -5.13M | -28.82M | |||
| Capital Expenditure | -3.09M | -3.23M | null | null | null | |||
| FREE CASH FLOW | -4.46M | -5.17M | -1.39M | -5.13M | -28.82M | |||
All data in USD